[1]
Mansour-Ghanaei, F., Samadi, A., Joukar, F., Tirgar Fakheri, H., Hassanipour, S., Ashoobi, M.T., Soltanipour, S., Alizadeh, A., Rezamand, G. and Fathalipour, M. 2019. Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial. EXCLI Journal. 18, (Aug. 2019), 644–652. DOI:https://doi.org/10.17179/excli2019-1613.